250 related articles for article (PubMed ID: 19139739)
1. Allogeneic hematopoietic SCT for patients with autoimmune diseases.
Daikeler T; Hügle T; Farge D; Andolina M; Gualandi F; Baldomero H; Bocelli-Tyndall C; Brune M; Dalle JH; Urban C; Ehninger G; Gibson B; Linder B; Lioure B; Marmont A; Matthes-Martin S; Nachbaur D; Schuetz P; Tyndall A; van Laar JM; Veys P; Saccardi R; Gratwohl A;
Bone Marrow Transplant; 2009 Jul; 44(1):27-33. PubMed ID: 19139739
[TBL] [Abstract][Full Text] [Related]
2. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.
Passweg JR; Rabusin M; Musso M; Beguin Y; Cesaro S; Ehninger G; Espigado I; Iriondo A; Jost L; Koza V; Lenhoff S; Lisukov I; Locatelli F; Marmont A; Philippe P; Pilatrino C; Quartier P; Stary J; Veys P; Vormoor J; Wahlin A; Zintl F; Bocelli-Tyndall C; Tyndall A; Gratwohl A;
Br J Haematol; 2004 Jun; 125(6):749-55. PubMed ID: 15180864
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation in autoimmune diseases: the Ahmedabad experience.
Vanikar AV; Modi PR; Patel RD; Kanodia KV; Shah VR; Trivedi VB; Trivedi HL
Transplant Proc; 2007 Apr; 39(3):703-8. PubMed ID: 17445577
[TBL] [Abstract][Full Text] [Related]
6. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
[TBL] [Abstract][Full Text] [Related]
7. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.
Farge D; Passweg J; van Laar JM; Marjanovic Z; Besenthal C; Finke J; Peter HH; Breedveld FC; Fibbe WE; Black C; Denton C; Koetter I; Locatelli F; Martini A; Schattenberg AV; van den Hoogen F; van de Putte L; Lanza F; Arnold R; Bacon PA; Bingham S; Ciceri F; Didier B; Diez-Martin JL; Emery P; Feremans W; Hertenstein B; Hiepe F; Luosujärvi R; Leon Lara A; Marmont A; Martinez AM; Pascual Cascon H; Bocelli-Tyndall C; Gluckman E; Gratwohl A; Tyndall A;
Ann Rheum Dis; 2004 Aug; 63(8):974-81. PubMed ID: 15249325
[TBL] [Abstract][Full Text] [Related]
8. Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias.
Passweg JR; Rabusin M
Autoimmunity; 2008 Dec; 41(8):660-5. PubMed ID: 18958755
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation for severe autoimmune diseases.
Gratwohl A
Autoimmunity; 2008 Dec; 41(8):673-8. PubMed ID: 18958760
[TBL] [Abstract][Full Text] [Related]
10. Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation.
Cesaro S; Marsh J; Tridello G; Rovò A; Maury S; Montante B; Masszi T; Van Lint MT; Afanasyev B; Iriondo Atienza A; Bierings M; Carbone C; Doubek M; Lanino E; Sarhan M; Risitano A; Steinerova K; Wahlin A; Pegoraro A; Passweg J
Acta Haematol; 2010; 124(1):19-22. PubMed ID: 20606411
[TBL] [Abstract][Full Text] [Related]
11. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Gratwohl A; Stern M; Brand R; Apperley J; Baldomero H; de Witte T; Dini G; Rocha V; Passweg J; Sureda A; Tichelli A; Niederwieser D;
Cancer; 2009 Oct; 115(20):4715-26. PubMed ID: 19642176
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children.
Rabusin M; Snowden JA; Veys P; Quartier P; Dalle JH; Dhooge C; Di Bartolomeo P; Gonzalez-Vicent M; Gibson B; Iriondo A; Juergens H; Lisukov I; Messina C; Mialou V; Steward CG; Urban C; Renard M; Giurici N; Peters C; Badoglio M; Ronfani L; Dini G; Farge D; Saccardi R;
Biol Blood Marrow Transplant; 2013 Apr; 19(4):666-9. PubMed ID: 23253561
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune disease after autologous hematopoietic stem cell transplantation.
Bohgaki T; Atsumi T; Koike T
Autoimmun Rev; 2008 Jan; 7(3):198-203. PubMed ID: 18190878
[TBL] [Abstract][Full Text] [Related]
14. Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; van Laar JM; Farge D; Andolina M; Arnold R; Carreras E; Finke J; Kötter I; Kozak T; Lisukov I; Löwenberg B; Marmont A; Moore J; Saccardi R; Snowden JA; van den Hoogen F; Wulffraat NM; Zhao XW; Tyndall A;
Bone Marrow Transplant; 2005 May; 35(9):869-79. PubMed ID: 15765114
[TBL] [Abstract][Full Text] [Related]
15. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature.
Daikeler T; Kötter I; Bocelli Tyndall C; Apperley J; Attarbaschi A; Guardiola P; Gratwohl A; Jantunen E; Marmont A; Porretto F; Musso M; Maurer B; Rinaldi N; Saccardi R; Tyndall A;
Ann Rheum Dis; 2007 Feb; 66(2):202-7. PubMed ID: 16950809
[TBL] [Abstract][Full Text] [Related]
17. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
18. Place of HSCT in treatment of childhood AML.
Klingebiel T; Reinhardt D; Bader P;
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S7-9. PubMed ID: 18978749
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
[TBL] [Abstract][Full Text] [Related]
20. Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.
Claviez A; Sureda A; Schmitz N
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S16-24. PubMed ID: 18978738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
